China Pharma Holdings, Inc.
CPHI· NYSE
CPHIChina Pharma Holdings, Inc.
Quarterly figures for China Pharma Holdings, Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
China Pharma Holdings, Inc. has filed its 10-Q within 43 to 45 days of period end across its last 8 quarters. The 10-K runs 85 to 92 days.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $948.34K | −7.5% | -$0.04 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | $983.54K | −13.4% | -$0.04 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 1, 2026 | 91 d | 10-K | $1.23M | +8.1% | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 12, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 31, 2025 | 90 d | 10-K | $1.13M | −47.2% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 13, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | $2.15M | −26.4% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 30, 2023 | 89 d | 10-K | $2.92M | +1.1% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 30, 2022 | 89 d | 10-K | $2.89M | −1.4% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 26, 2021 | 85 d | 10-K | $2.93M | −3.8% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 30, 2020 | 90 d | 10-K | $3.05M | −6.0% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Mar 28, 2019 | 87 d | 10-K | $3.24M | −15.7% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | ||||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Apr 2, 2018 | 92 d | 10-K | $3.85M | −26.9% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 14, 2017 | ||||||
| FY 2016 | |||||||||
| Q4 2016derived | Dec 31, 2016 | — | Mar 31, 2017 | 90 d | 10-K | $5.26M | +16.8% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | ||||||
| FY 2015 | |||||||||
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | $4.50M | +35.2% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 16, 2015 | ||||||
| FY 2014 | |||||||||
| Q4 2014derived | Dec 31, 2014 | — | Mar 30, 2015 | 89 d | 10-K | $3.33M | −60.4% | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 14, 2014 | ||||||
| FY 2013 | |||||||||
| Q4 2013derived | Dec 31, 2013 | — | Mar 20, 2014 | 79 d | 10-K | $8.41M | −27.7% | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 14, 2013 | ||||||
| FY 2012 | |||||||||
| Q4 2012derived | Dec 31, 2012 | — | Mar 14, 2013 | 73 d | 10-K | $11.65M | −48.1% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 14, 2012 | ||||||
| FY 2011 | |||||||||
| Q4 2011derived | Dec 31, 2011 | — | Mar 14, 2012 | 74 d | 10-K | $22.46M | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 10, 2011 | ||||||
| FY 2010 | |||||||||
| Q4 2010derived | Dec 31, 2010 | — | Mar 3, 2011 | 62 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 10, 2010 | 41 d | 10-Q | ||||
| 43 d |
| 10-Q |
| $756.22K |
| −31.3% |
| -$0.17 |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $1.03M | +10.9% | -$0.16 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 14, 2025 | 44 d | 10-Q | $1.14M | −17.0% | -$0.24 |
|---|
| 44 d |
| 10-Q |
| $1.10M |
| −39.0% |
| -$0.65 |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | $924.94K | −15.8% | -$0.89 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $1.37M | −30.1% | -$0.72 |
|---|
| 44 d |
| 10-Q |
| $1.80M |
| −8.3% |
| -$0.29 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $1.10M | −31.9% | -$0.35 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | $1.96M | +22.2% | -$0.06 |
|---|
| 45 d |
| 10-Q |
| $1.97M |
| −0.6% |
| -$0.16 |
| Q2 2022 | Jun 30, 2022 | — | Aug 11, 2022 | 42 d | 10-Q | $1.61M | −33.2% | -$0.18 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 12, 2022 | 42 d | 10-Q | $1.60M | −32.0% | -$0.22 |
|---|
| 43 d |
| 10-Q |
| $1.98M |
| −17.6% |
| -$0.02 |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | $2.42M | −35.9% | -$0.02 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 14, 2021 | 44 d | 10-Q | $2.36M | +33.7% | -$0.02 |
|---|
| 44 d |
| 10-Q |
| $2.40M |
| +1.0% |
| -$0.02 |
| Q2 2020 | Jun 30, 2020 | — | Aug 13, 2020 | 44 d | 10-Q | $3.77M | +46.8% | $0.00 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 14, 2020 | 44 d | 10-Q | $1.76M | −39.8% | -$0.02 |
|---|
| 45 d |
| 10-Q |
| $2.38M |
| +3.4% |
| -$0.02 |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | $2.57M | −19.0% | -$0.02 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 14, 2019 | 44 d | 10-Q | $2.93M | −19.0% | -$0.01 |
|---|
| 45 d |
| 10-Q |
| $2.30M |
| −27.3% |
| -$0.04 |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $3.17M | +8.8% | -$0.02 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 14, 2018 | 44 d | 10-Q | $3.62M | +10.1% | -$0.01 |
|---|
| 45 d |
| 10-Q |
| $3.16M |
| +1.2% |
| -$0.05 |
| Q2 2017 | Jun 30, 2017 | — | Aug 14, 2017 | 45 d | 10-Q | $2.92M | −17.6% | -$0.05 |
|---|
| Q1 2017 | Mar 31, 2017 | — | May 11, 2017 | 41 d | 10-Q | $3.29M | −9.8% | -$0.02 |
|---|
| 45 d |
| 10-Q |
| $3.13M |
| −30.2% |
| -$0.04 |
| Q2 2016 | Jun 30, 2016 | — | Aug 11, 2016 | 42 d | 10-Q | $3.54M | −37.6% | -$0.06 |
|---|
| Q1 2016 | Mar 31, 2016 | — | May 16, 2016 | 46 d | 10-Q | $3.64M | −36.1% | -$0.04 |
|---|
| 47 d |
| 10-Q |
| $4.48M |
| −19.5% |
| $0.07 |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $5.67M | −7.4% | $0.03 |
|---|
| Q1 2015 | Mar 31, 2015 | — | May 11, 2015 | 41 d | 10-Q | $5.69M | −19.9% | -$0.09 |
|---|
| 45 d |
| 10-Q |
| $5.57M |
| −31.4% |
| -$0.15 |
| Q2 2014 | Jun 30, 2014 | — | Aug 14, 2014 | 45 d | 10-Q | $6.13M | −23.6% | -$0.20 |
|---|
| Q1 2014 | Mar 31, 2014 | — | May 15, 2014 | 45 d | 10-Q | $7.11M | −13.9% | -$0.05 |
|---|
| 45 d |
| 10-Q |
| $8.12M |
| −33.3% |
| -$0.05 |
| Q2 2013 | Jun 30, 2013 | — | Aug 14, 2013 | 45 d | 10-Q | $8.03M | −45.0% | -$0.10 |
|---|
| Q1 2013 | Mar 31, 2013 | — | May 14, 2013 | 44 d | 10-Q | $8.25M | −48.7% | -$0.06 |
|---|
| 45 d |
| 10-Q |
| $12.18M |
| −42.0% |
| $0.03 |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $14.60M | −25.5% | $0.04 |
|---|
| Q1 2012 | Mar 31, 2012 | — | May 14, 2012 | 44 d | 10-Q | $16.09M | −11.2% | $0.06 |
|---|
| 41 d |
| 10-Q |
| $20.99M |
| +12.4% |
| $0.11 |
| Q2 2011 | Jun 30, 2011 | — | Aug 10, 2011 | 41 d | 10-Q | $19.60M | +17.9% | $0.12 |
|---|
| Q1 2011 | Mar 31, 2011 | — | May 10, 2011 | 40 d | 10-Q | $18.12M | — | $0.12 |
|---|
| $18.68M |
| — |
| $0.14 |
| Q2 2010 | Jun 30, 2010 | — | Aug 9, 2010 | 40 d | 10-Q | $16.63M | — | $0.14 |
|---|
